| Literature DB >> 29891972 |
Valencia Hui Xian Foo1, Yasuo Yanagi1,2, Quang Duc Nguyen1, Charumathi Sabanayagam1,3, Sing Hui Lim4, Kumari Neelam1,2, Jie Jin Wang5, Paul Mitchell6, Ching-Yu Cheng1,2,3, Tien Yin Wong1,2,4, Chui Ming Gemmy Cheung7,8,9.
Abstract
We aimed to determine the 6-year incidence and risk factors of age-related macular degeneration (AMD) in first and second generations of Singaporean Indians. Baseline examination was conducted in 2007-9 and 6-year propsective follow-up examination of this Indian population in 2013-5. All participants underwent interviews with questionnaires and comprehensive medical and eye examinations. Incidence was age-standardized to Singaporean 2010 census. Risk factors associated with AMD incidence were assessed and compared between first and second generations of immigrants. Among 2200 persons who participated in the follow-up examination (75.5% response rate), gradable fundus photographs were available in 2105. The 6-year age-standardized incidences of early and late AMD were 5.26% and 0.51% respectively. Incident early AMD was associated with cardiovascular disease history (HR 1.59, 95% CI 1.04-2.45), underweight body mass index (BMI) (HR 3.12, 95% CI 1.37-7.14) (BMI of <18.5 vs 18.51-25 kg/m2), heavy alcohol drinking (HR 3.14 95% CI 1.25-7.89) and ARMS2 rs3750847 homozygous genetic loci carrier (HR 2.52, 95% CI 1.59-3.99). We found a relatively low incidence of early AMD in this Singaporean Indian population compared to Caucasian populations. Both first and second-generation Indian immigrants have similar incidence and risk factor patterns for early AMD.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29891972 PMCID: PMC5995892 DOI: 10.1038/s41598-018-27202-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline Characteristics of Participants and according to first and second generation.
| Variable* | Participants at both examinations | First Generation | Second Generation | P value | |||
|---|---|---|---|---|---|---|---|
| (n = 2105) | (n = 793)† | (n = 1312)†† | |||||
| Mean or n | SD or % | Mean or n (%) | SD or % | Mean or n (%) | SD or % | ||
| Age (years) | 56.20 | 9.07 | 59.54 | 10.22 | 54.18 | 7.62 | <0.001 |
| Sex, Male | 1047 | 49.74 | 400 | 50.44 | 647 | 49.31 | 0.93 |
| Hypertension, yes | 1177 | 55.99 | 486 | 61.29 | 691 | 52.79 | 0.34 |
| Systolic Blood Pressure, (mmHg) | 134.11 | 19.30 | 135.97 | 19.56 | 132.99 | 19.06 | 0.29 |
| Diastolic Blood Pressure, (mmHg) | 77.75 | 10.11 | 77.11 | 9.77 | 78.14 | 10.30 | 0.38 |
| Diabetes | 570 | 27.17 | 235 | 29.67 | 335 | 25.65 | 0.18 |
| Hba1c, % | 6.36 | 1.32 | 6.33 | 1.22 | 6.38 | 1.37 | 0.04 |
| Chronic Kidney Disease | 105 | 5.16 | 49 | 6.36 | 56 | 4.43 | 0.08 |
| Blood Creatinine (mmol/l) | 0.85 | 0.25 | 0.86 | 0.24 | 0.85 | 0.26 | 0.32 |
| History of Myocardial Infarction | 162 | 7.70 | 72 | 9.09 | 90 | 6.86 | 0.13 |
| History of Stroke | 43 | 2.04 | 19 | 2.40 | 24 | 1.83 | 0.87 |
| Body Mass Index (kg/m2) | 26.20 | 4.48 | 25.82 | 3.98 | 26.44 | 4.74 | 0.01 |
| Total Cholesterol (mg/dl) | 5.21 | 1.07 | 5.07 | 1.04 | 5.29 | 1.08 | <0.001 |
| HDL Cholesterol (mg/dl) | 1.06 | 0.31 | 1.05 | 0.31 | 1.07 | 0.30 | 0.01 |
| LDL Cholesterol (mg/dl) | 3.35 | 0.93 | 3.25 | 0.92 | 3.41 | 0.92 | 0.10 |
| Triglycerides (mg/dl) | 1.96 | 1.17 | 1.94 | 1.15 | 1.98 | 1.19 | 0.60 |
| C-reactive Protein (mg/l), mgL | 4.08 | 5.75 | 3.65 | 5.61 | 4.34 | 5.81 | 0.02 |
| Formal Education, yes | 1787 | 84.97 | 621 | 78.41 | 1166 | 88.94 | 0.58 |
| Low income, <$2000 | 1440 | 70.24 | 545 | 70.96 | 895 | 69.81 | 0.28 |
| Low Economic Status*, yes | 967 | 47.19 | 366 | 47.72 | 601 | 46.88 | 0.02 |
| Cigarette Smoking status | 0.13 | ||||||
| Never smoked | 1570 | 74.58 | 624 | 78.69 | 946 | 72.10 | |
| Current smoker | 285 | 13.54 | 71 | 8.95 | 214 | 16.31 | |
| Past Smoker | 246 | 11.69 | 98 | 12.36 | 148 | 11.28 | |
| Alcohol Intake, yes | 273 | 12.98 | 93 | 11.74 | 180 | 13.73 | 0.21 |
| Moderate drinking (1 to 3 days of drinking a week) | 231 | 10.98 | 76 | 9.60 | 155 | 11.82 | 0.30 |
| Heavy drinking (4 to 7 days of drinking a week) | 42 | 2.00 | 17 | 2.15 | 25 | 1.91 | |
| Refractive Error | |||||||
| Myopia | 522 | 24.80 | 186 | 23.46 | 336 | 25.61 | 0.90 |
| Emmetropia | 803 | 38.15 | 287 | 36.19 | 516 | 39.33 | |
| Hyperopia | 741 | 35.20 | 303 | 38.21 | 438 | 33.38 | |
| Cataract Surgery | 238 | 11.33 | 139 | 17.57 | 99 | 7.56 | 0.70 |
| Axial length (mm)¶ | 22.76 | 3.99 | 22.44 | 4.47 | 22.95 | 3.66 | 0.02 |
| Spherical equivalent¶ | −0.07 | 2.06 | 0.11 | 1.76 | −0.18 | 2.21 | 0.51 |
| CFH rs10801555 | |||||||
| Non-carrier | 700 | 33.25 | 300 | 37.83 | 400 | 30.49 | 0.25 |
| Heterozygote | 694 | 32.97 | 281 | 35.44 | 413 | 31.48 | |
| Homozygote | 176 | 8.36 | 65 | 8.20 | 111 | 8.46 | |
| ARMS2 rs3750847 | |||||||
| Non-carrier | 671 | 31.88 | 265 | 33.42 | 406 | 30.95 | 0.38 |
| Heterozygote | 717 | 34.06 | 294 | 37.07 | 423 | 32.24 | |
| Homozygote | 182 | 8.65 | 87 | 10.97 | 95 | 7.24 | |
SD = standard deviation;
†First generation participants are those who are born outside of Singapore (m = 793).
††Second generation participants are those who are born in Singapore, and whose parents are of Indian origins (n = 1312).
*Low economic status defined as participants with primary or lower education only and individual monthly income <$2,000 Singapore dollars. ±P-values is between first and second-generation immigrants. For continuous variables, adjusted t-tests for age were done; while for discrete variables, Logistic/Poisson Regression controlling for age were performed to check whether the two samples were having the same distribution.
¶Ocular values of affected eye. If not affected with AMD, then the right eye is taken. If both eyes are affected, then right eye is taken.
Multivariable-adjusted Associations between Risk Factors and Incident Early AMD in SINDI II.
| Variable* | Overall | First generation | Second generation | |||||
|---|---|---|---|---|---|---|---|---|
| Model 1† (N = 3994) | Multivariable adjusted†† (N = 3994) | Multivariable adjusted††† (N = 1472) | Multivariable adjusted††† (N = 2522) | |||||
| Risk Ratio | Risk Ratio | Risk Ratio | Risk Ratio | |||||
| (95% CI) | p-value | (95% CI) | p-value | (95% CI) | p-value | (95% CI) | p-value | |
| Age, years | 1.08 (1.06–1.1) | <0.001 | 1.07 (1.05–1.09) | <0.001 | 1.06 (1.03–1.09) | <0.001 | 1.08 (1.05–1.12) | <0.001 |
| Sex | ||||||||
| Female | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Male | 0.87 (0.62–1.23) | 0.43 | 0.67 (0.45–1.00) | 0.05 | 0.55 (0.31–0.96) | 0.04 | 0.84 (0.47–1.49) | 0.55 |
| Hypertension | 1.34 (0.91–1.98) | 0.14 | 1.26 (0.85–1.88) | 0.25 | 1.11 (0.63–1.95) | 0.72 | 1.35 (0.76–2.4) | 0.31 |
| Total cholesterol | 0.88 (0.73–1.07) | 0.20 | 0.98 (0.87–1.10) | 0.70 | 0.91 (0.79–1.05) | 0.18 | 1.08 (0.87–1.34) | 0.49 |
| Cardiovascular disease history | 1.68 (1.11–2.54) | 0.01 | 1.59 (1.04–2.45) | 0.03 | 1.7 (0.96–3) | 0.07 | 1.72 (0.88–3.34) | 0.11 |
| Body Mass Index (kg/m2), per SD | 0.97 (0.8–1.18) | 0.77 | 1.09 (0.87–1.38) | 0.44 | 1.4 (0.86–2.28) | 0.18 | 0.97 (0.69–1.35) | 0.84 |
| Underweight (16.0–18.5) | 3.26 (1.43–7.41) | 0.005 | 3.12 (1.37–7.14) | 0.01 | 2.21 (0.72–6.76) | 0.16 | 4.71 (1.29–17.26) | 0.02 |
| Normal (18.51–25) | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Overweight (25.1–30) | 1.04 (0.7–1.55) | 0.84 | 1 (0.67–1.48) | 0.99 | 0.74 (0.43–1.26) | 0.27 | 1.52 (0.82–2.83) | 0.18 |
| Obese (>30) | 0.99 (0.92–1.05) | 0.67 | 1 (0.94–1.07) | 0.97 | 1.03 (0.94–1.14) | 0.49 | 0.95 (0.87–1.04) | 0.29 |
| Current smoker | 1.13 (0.64–2.01) | 0.67 | 0.87 (0.47–1.59) | 0.64 | 1.2 (0.51–2.81) | 0.68 | 0.74 (0.31–1.74) | 0.49 |
| Alcohol Frequency | ||||||||
| Non-drinker | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
| Moderate drinker | 1.71 (1.01–2.91) | 0.05 | 1.68 (0.97–2.9) | 0.06 | 1.23 (0.57–2.68) | 0.60 | 2.15 (1–4.6) | 0.05 |
| Heavy drinker | 3.05 (1.22–7.64) | 0.02 | 3.14 (1.25–7.89) | 0.02 | 2.63 (0.74–9.33) | 0.13 | 3.39 (0.88–12.99) | 0.08 |
| Serum C-reactive Protein | 1.01 (0.98–1.03) | 0.68 | 1.01 (0.99–1.04) | 0.33 | 0.99 (0.95–1.03) | 0.63 | 1.03 (1–1.06) | 0.09 |
| Genetic Loci | ||||||||
| CFH | ||||||||
| Ref | ||||||||
| Heterozygote | 1.15 (0.77–1.71) | 0.50 | 1.21 (0.83–1.77) | 0.32 | 1.5 (0.89–2.51) | 0.13 | 1.01 (0.57–1.78) | 0.97 |
| Homozygote | 0.8 (0.38–1.67) | 0.55 | 0.9 (0.44–1.85) | 0.77 | 1.45 (0.58–3.62) | 0.43 | 0.52 (0.15–1.82) | 0.31 |
| ARMS2 | ||||||||
| Ref | ||||||||
| Heterozygote | 0.87 (0.56–1.35) | 0.54 | 0.92 (0.62–1.38) | 0.69 | 0.97 (0.55–1.72) | 0.93 | 0.83 (0.47–1.49) | 0.54 |
| Homozygote | 2.39 (1.45–3.95) | <0.001 | 2.52 (1.59–3.99) | <0.001 | 2.27 (1.22–4.21) | 0.01 | 2.78 (1.36–5.68) | 0.01 |
Numbers are too small to generate any significant values in the analysis.
†Model 1: adjusting for age and gender.
††Multivariate model: adjusting for age, gender, hypertension, total cholesterol, cardiovascular disease, BMI categories, smoking status, alcohol consumption frequency and ARMS2 genetic loci.
†††Multivariate model: adjusting for age, gender, hypertension, total cholesterol, cardiovascular disease, BMI categories, smoking status, alcohol consumption frequency, serum C-reactive protein and ARMS2 genetic loci.